Figure 3.
The time course for participant 2. This patient achieved tolerance as noted by a negative inhibitor titer, presence of FVIII antigen, and an FVIII activity of 15%.
The time course for participant 2. This patient achieved tolerance as noted by a negative inhibitor titer, presence of FVIII antigen, and an FVIII activity of 15%.
